Obesity Disorder Articles & Analysis
8 news found
“FDA clearance of our GIBI HD™ calibration tube, which supports bariatric procedures across the spectrum, marks an important addition to our suite of physician led weight loss solutions and we look forward to formally introducing this important new product at the International Federation for the Surgery of Obesity and Metabolic Disorders – IFSO ...
Neurovalens, a global leader of neuro-technology products, is embarking on the development of a device for the treatment of obesity with £1m support from Invest NI. The technology is based on the neuro stimulation of specific areas of the brain responsible for influencing appetite and cravings. The company specialises in combining neuroscience and technology to tackle ...
Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. ...
Camurus (NASDAQ STO: CAMX) today announces that the company’s license partner Rhythm Pharmaceuticals has dosed the first patients in a Phase 3 trial evaluating weekly setmelanotide subcutaneous depot in patients six years of age and older with a rare genetic disease of obesity. “We are pleased with the progress of our collaboration with Rhythm and today’s ...
"Through this collaboration, we will have the opportunity to expand treatment options available to patients suffering from metabolic disorders," said Ruth Gimeno, Ph.D., vice president, diabetes research and clinical investigation at Lilly. "Regor's technology will also allow Lilly to further accelerate innovation and deliver breakthrough therapies in obesity and ...
Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines , and working to prevent and ultimately cure disease. ...
"In addition to treating Parkinson’s disease, we can also adapt our technology to other disease states being investigated for treatment with DBS such as Alzheimer's disease, depression, epilepsy, obsessive-compulsive disorder, and obesity." About DBI Deep Brain Innovations (DBI) is a medical device company that has developed a proprietary method to ...
The study seeks information to prevent and treat some of the nation's most pressing health problems, including autism, birth defects, diabetes, heart disease and obesity. The study defines the term environment broadly, including natural and manufactured environment factors, biological and chemical factors, physical surroundings, social factors, behavioral influences and ...